OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$8.98 USD
+0.15 (1.70%)
Updated Aug 7, 2024 09:30 AM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 1 - 20 ( 124 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Rebound Emergence Confirmed by 1Q24 Pre-Announcement DAAP Momentum
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Preliminary Earnings Data Support Bullish Thesis
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Acquisition and Cost Controls Set To Increase Revenue and Earnings Scale
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Slow Growth Rebound Emerging But Behind Expectations; PT Cut to $20.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Midyear Strategic Update" Affirms Growth Rebound Expectation
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Pharma Spending Weakness Persists But Glimmers of Hope Emerging
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Weak Yr/Yr Results Belie Early Strength Signals From New RWE Offering
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R